Skip to main content

Advertisement

Table 2 Prevalence of MES in various patient subgroups along with OR for the subgroups that are significantly associated with MES (n = 40).

From: Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?

Group   % OR p-value
Age < 65 5.9 9 0.03
  ≥ 65 36.4   
Sex Male 20.7   0.26
  Female 36.4   
Stroke type Stroke 24.3   0.58
  TIA 0   
NIHSS 0-7 15 Ref 0.02
  8-13 8.3 14  
  > 13 71.4 28  
Intravenous thrombolysis Yes 29.2   0.36
  No 18.8   
Etiology-TOAST Embolic 33.3 7 0.06
  Non-embolic 12.5   
Intracranial stenosis No 16.7 10 0.04
  Yes 66.7   
Previous stroke/TIA No 14.8 4.8 0.06
  Yes 45.5   
Atrial fibrillation No 23.1   0.13
  yes 60   
Active Smokers No 28   0.6
  yes 25   
  1. * OR calculated using Chi-square for dichotomous variables and logistic regression for polytomous variables.
  2. NIHSS = National Institute of Health Stroke Scale
  3. TOAST = Trial of Org 10172 in Acute Stroke Treatment
  4. TIA = Transient ischemic attack